Yuqin Song

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Diffuse Large B Cell Lymphoma

Acute Lymphoblastic Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yuqin Song, Zhengming Jin, Zhi-Ming Li, Yan-Yan Liu, Lanfang Li, Chuan He, Hang Su, Hui Zhou, Kunyan Li, Siguo Hao, Xuelan Zuo, Jianyuan Wu, Xiaojian Zhu, Meng Wu, Xiuhua Sun, Junyuan Qi, Zhen Cai, Zhenjiang Li, Yijing Li, Yanhua Huang, Jie Shen, Zhenyu Xiao, Jun Zhu
Enhancer of zeste homolog 2 inhibitor SHR2554 in relapsed or refractory peripheral T-cell lymphoma: data from the first-in-human phase 1 study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yuqin Song, Zhengming Jin, Zhi-Ming Li, Yan-Yan Liu, Lanfang Li, Chuan He, Hang Su, Hui Zhou, Kunyan Li, Siguo Hao, Xuelan Zuo, Jianyuan Wu, Xiaojian Zhu, Meng Wu, Xiuhua Sun, Junyuan Qi, Zhen Cai, Zhenjiang Li, Yijing Li, Yanhua Huang, Jie Shen, Zhenyu Xiao, Jun Zhu
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Tingyu Wang, Xiuhua Sun, Lihua Qiu, Hang Su, Junning Cao, Zhi-Ming Li, Yuqin Song, Li Zhang, Xiaojian Zhu, Huijing Wu, Wei Zhang, Junmin Li, Ke-Shu Zhou, Hui Zhou, Yu Yang, Zhifeng Li, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei Li, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zhenjiang Li, Shuhua Yi, Hanying Bao, Zusheng Xu, Lugui Qiu
The oral PI3Kδ inhibitor linperlisib for the treatment of relapsed and/or refractory follicular lymphoma: A phase 2, single-arm, open-label clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)